This role owns the medical strategy and execution for a novel Interleukin-33 targeting monoclonal antibody, crafting both product and disease area direction across the full lifecycle
Job Summary
This role owns the medical strategy and execution for a novel Interleukin-33 targeting monoclonal antibody, crafting both product and disease area direction across the full lifecycle.
Lead and grow the COPD US medical team, setting clear vision, priorities and standards for excellence in disease area and brand strategy and execution.
Nurture a culture that values scientific rigor, teamwork, innovation and recognition, while maintaining full compliance with AstraZeneca policies and external regulations.
Matching Summary
This role owns the medical strategy and execution for a novel Interleukin-33 targeting monoclonal antibody, crafting both product and disease area direction across the full lifecycle.
Skills & Requirements
Must-have
Scientific depth and strategic leadership
Advance care in chronic respiratory disease
Novel Interleukin-33 targeting antibody
Transforming Healthcare initiatives
Medical spokesperson for COPD
Nice-to-have
Inspire life-changing medicines
Embrace change and spark innovation
Continuous development without borders
Key Requirements
Sophisticated Scientific Degree or equivalent
Minimum of 7 years pharmaceutical industry experience
Medical/clinical/scientific expertise in Respiratory Disease
Experienced team leader
Track record delivering results in a matrix environment